GET THE APP

..

Journal of Inflammatory Bowel Diseases & Disorders

ISSN: 2476-1958

Open Access

Infliximab in the Treatment of Ankylosing Spondylitis: A New Frontier

Abstract

Alemidia Gulva

Ankylosing Spondylitis (AS) is a chronic, inflammatory, and often
debilitating condition primarily affecting the axial skeleton, particularly the
sacroiliac joints and spine. It is part of a broader category of diseases known
as spondyloarthritis, which is characterized by inflammation of the joints and
entheses (sites where tendons and ligaments attach to bones). AS typically
manifests in early adulthood and is more common in men, often leading to
significant pain, stiffness, and eventual fusion of the spine if left untreated.
This condition can severely impact mobility and quality of life, making early
intervention crucial for controlling inflammation and preventing irreversible
damage to the joints.

PDF

Share this article

Google Scholar citation report
Citations: 77

Journal of Inflammatory Bowel Diseases & Disorders received 77 citations as per Google Scholar report

Journal of Inflammatory Bowel Diseases & Disorders peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward